Navigation

Clinical Research

Our team of highly trained specialists is dedicated to offering patients the most advanced treatment available for their condition through clinical research.

Adult Neurology Clinical Trials

If you are interested in learning more about one of our ongoing clinical trials, please feel free to call our Clinical Research Program at 520-320-2147.

Alzheimer’s Disease Clinical Trial – Now Enrolling

Early Alzheimer’s Disease: ENGAGE

The ENGAGE Study is a global study assessing the efficacy and safety of an investigational medication, to determine whether it can slow the progression of symptoms in early Alzheimer’s disease.

Alzheimer’s Disease Clinical Trial – Now Enrolling

Mild Alzheimer’s Study: DAYBREAK
The DAYBREAK study is looking at the effect of an oral investigational drug on mild Alzheimer’s disease.

Multiple Sclerosis Clinical Trial – Now Enrolling

Multiple Sclerosis Study: PASSAGE
The PASSAGE study is a long-term study monitoring safety in patients newly started on pharmaceutical therapy for MS.

Relapsing Multiple Sclerosis Clinical Trial – Now Enrolling

Relapsing Multiple Sclerosis Study: ASCLEPIOS
The ASCLEPIOS study is comparing the safety and efficacy of one oral medication against another in relapsing MS.

Glioblastoma Clinical Trial – Now Enrolling

Recurrent Glioblastoma Study
This study is of an investigational oral medication in patients with recurrent glioblastoma.

Glioblastoma Clinical Trial – Now Enrolling

Recurrent Glioblastoma Study – VOYAGER

The VOYAGER study is a feasibility study of a device worn on the head for recurrent glioblastoma.

Spinal Stenosis Clinical Trial – Now Enrolling

Spinal Stenosis Study – COFLEX

The COFLEX study is a comparative evaluation study in the treatment of spinal stenosis with and without additional stabilization.